Moshkevich Solomon sold 9 shares of Natera, Inc. at $388.20 for −$3.49k on Nov 2, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
PRESIDENT, CLINICALDIAGNOSTICS
PRESIDENT, CLINICALDIAGNOSTICS
Filed Nov 4, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$3,493.80Shares × reported price
Shares traded
9Common Stock
Price per share
$388.20Reported price. Read footnotes for ranges.
% of reported position traded
<0.01%This security and ownership context
Holdings after
104,733Direct
Trade date
Nov 2, 2026Sell
Filed
Nov 4, 2026, 9:35 PM ET3-day reporting delay
Accession
0002010019-26-000038Code S · Transaction 393139
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 104,742 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 2, 2026Sell410$400.29−$164,120.62Trade 393140
Nov 2, 2026Sell200$405.26−$81,051.20Trade 393141
Nov 2, 2026Sell432$406.94−$175,797.99Trade 393142
Nov 2, 2026Sell408$408.08−$166,498.31Trade 393143
Nov 2, 2026Sell520$409.46−$212,918Trade 393144
Nov 2, 2026Sell120$410.72−$49,285.80Trade 393145
Nov 2, 2026Sell120$411.73−$49,408Trade 393146
Nov 2, 2026Sell120$412.88−$49,546Trade 393147
Nov 2, 2026Sell80$414.16−$33,132.60Trade 393148
Nov 2, 2026Sell760$415.52−$315,794.97Trade 393149
Nov 2, 2026Sell240$416.45−$99,946.99Trade 393150
12 transaction rows in this filing. Joint filers share the same rows.

NTRA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
NTRA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +13%1w ago +11%1d ago +14%
Returns since7d −12%30d90d180d1y

Footnotes in full

F1: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025. F2: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024. F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $404.8500 to $405.8450 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $406.4150 to $407.3750 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $407.5550 to $408.4100 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $409.13 to $409.94 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F7: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $410.21 to $411.13 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $411.4300 to $411.8850 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F9: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $412.6200 to $413.0150 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F10: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $413.8100 to $414.5050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F11: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $414.9450 to $415.6400 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F12: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $416.18 to $416.73 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.